Compumedics Limited (ASX:CMP)

Australia flag Australia · Delayed Price · Currency is AUD
0.2850
0.00 (0.00%)
Jun 6, 2025, 3:31 PM AEST
Market Cap 54.73M
Revenue (ttm) 47.37M
Net Income (ttm) -1.59M
Shares Out 192.04M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE 28.50
Dividend n/a
Ex-Dividend Date n/a
Volume 250
Average Volume 19,788
Open 0.2850
Previous Close 0.2850
Day's Range 0.2850 - 0.2850
52-Week Range 0.2450 - 0.3650
Beta 0.52
RSI 48.42
Earnings Date May 29, 2025

About Compumedics

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients’ physiological data; Somté PSG; Okti; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; Somté, an investigative tool; Siesta 802; and Somté PSG. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's hom... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1987
Employees 155
Stock Exchange Australian Securities Exchange
Ticker Symbol CMP
Full Company Profile

Financial Performance

In 2024, Compumedics's revenue was 50.26 million, an increase of 17.10% compared to the previous year's 42.92 million. Losses were -338,000, -94.48% less than in 2023.

Financial Statements

News

There is no news available yet.